Skeletal Muscle Mitochondria in Insulin Resistance: Differences in Intermyofibrillar Versus Subsarcolemmal Subpopulations and Relationship to Metabolic Flexibility
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; 10 of the 69 sources its claims cite were checked for support.
Abstract
Context: Insulin resistance is accompanied by lower lipid oxidation during fasting and metabolic inflexibility. Whether these abnormalities correlate with mitochondrial content in skeletal muscle is unknown. Objective: The objective of the study was to investigate whether decreased fasting lipid oxidation, metabolic inflexibility, and impaired glucose disposal correlate with reduced mitochondrial content in intermyofibrillar vs. subsarcolemmal (SS) subpopulations. Design: Forty sedentary adults with a wide spectrum of insulin sensitivity were studied: insulin-sensitive lean subjects, insulin-resistant nondiabetic subjects, and subjects with type 2 diabetes mellitus. Glucose disposal was measured by euglycemic clamp and [6,6-D2]-glucose methodology. Fuel oxidation and metabolic flexibility (during clamps) were assessed by indirect calorimetry. Maximum aerobic capacity was assessed by treadmill testing. Intermyofibrillar and SS mitochondrial content were measured by quantitative electron microscopy of muscle biopsy samples. Results: Intermyofibrillar mitochondrial content was lower in the insulin-resistant nondiabetic subjects and type 2 diabetes mellitus groups, significantly correlating with glucose disposal in both men (R = 0.72, P < 0.01) and women (R = 0.53, P < 0.01). In contrast, SS mitochondrial content was similar among groups. Lower intermyofibrillar mitochondrial content was not explained by mitochondrial size, altered fiber-type distribution, or differences in maximum aerobic capacity. Intermyofibrillar mitochondrial content was significantly correlated with fasting respiratory quotient (R = −0.46, P = 0.003) and metabolic flexibility (R = 0.38, P = 0.02). Conclusions: In obese-insulin-resistant subjects with or without diabetes, intermyofibrillar mitochondrial content is decreased. This is not entirely explained by fitness status or fiber-type composition. SS mitochondrial content is unaffected, suggesting independent mitochondrial pool regulation. Lower mitochondrial content correlates with lower fasting lipid oxidation and metabolic inflexibility, suggesting it may be intrinsically linked to abnormal fuel utilization patterns of obesity-associated insulin resistance.
Overview
CoChat Summary
TL;DR
In sedentary adults spanning insulin sensitivity to type 2 diabetes, lower skeletal muscle intermyofibrillar mitochondrial content—but not subsarcolemmal mitochondrial content—was associated with insulin resistance, lower fasting lipid oxidation, and metabolic inflexibility. The findings suggest distinct regulation of mitochondrial subpopulations and a link between intermyofibrillar mitochondria and abnormal fuel-use patterns in obesity-associated insulin resistance.
Key findings
- Intermyofibrillar mitochondrial content was lower in insulin-resistant nondiabetic subjects (23.5% lower) and in type 2 diabetes mellitus subjects (39.7% lower) versus insulin-sensitive lean controls; adjusted means were 3.75% (IS-Lean), 3.03% (IR-ND, P < 0.05), and 2.51% (T2DM, P < 0.01).
- Intermyofibrillar mitochondrial content correlated with glucose disposal in men (R = 0.72, P < 0.01) and women (R = 0.53, P < 0.01), whereas subsarcolemmal mitochondrial content was similar among groups and did not correlate with insulin resistance.
- Intermyofibrillar mitochondrial content correlated with fasting respiratory quotient (R = −0.46, P = 0.003) and metabolic flexibility (R = 0.38, P = 0.02); ΔRQ was lower in IR-ND (0.07 ± 0.01) and T2DM (0.05 ± 0.01) than IS-Lean (0.15 ± 0.02).
- Lower intermyofibrillar mitochondrial content was not explained by mitochondrial size, altered fiber-type distribution, or differences in maximum aerobic capacity.
Methods
- Forty sedentary adults were studied: insulin-sensitive lean controls (n = 12), insulin-resistant nondiabetic subjects (n = 17), and subjects with type 2 diabetes mellitus (n = 11).
- Insulin sensitivity was measured by euglycemic clamp with [6,6-D2]-glucose methodology; fuel oxidation and metabolic flexibility were assessed by indirect calorimetry; maximum aerobic capacity was assessed by treadmill testing; body composition was assessed by dual-energy x-ray absorptiometry.
- Intermyofibrillar and subsarcolemmal mitochondrial content were measured by quantitative electron microscopy/stereology of vastus lateralis muscle biopsies; fiber typing used immunohistochemistry. Group comparisons used one-way ANOVA, ANCOVA adjusted for VO2max/fat-free mass, and correlation analyses.
Limitations
- The paper states that what mediates the relationship between insulin resistance and mitochondria is not clear, that apparent relationships with glycemia were arguably spurious, and that obesity associations were inconsistent; it also notes that physical activity remains an important co-modulator of mitochondrial content.
- The text makes evident that the study is cross-sectional, so it cannot establish causality between mitochondrial content and insulin resistance or fuel oxidation patterns.
- The sample is small and restricted to sedentary adults, which limits generalizability; the paper also notes that mitochondrial content was measured rather than mitochondrial function directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 22 Not checked · 77 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although animal models of insulin resistance appear to have intact mitochondrial capacity (2, 3), humans with insulin resistance seem to have reduced mitochondrial capacity in skeletal muscle.”
What the sources say
- Supportedcites [2] 2. Holloway GP, Gurd BJ, Snook LA, Lally J, Bonen A. 2010. Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats. Diabetes 59:819–828 [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Abstract states that mitochondrial fatty-acid oxidation capacity is not downregulated in insulin-resistant animals. The Discussion (Mitochondrial content and rates of palmitate oxidation; page not provided) reports increased palmitate oxidation in mitochondria from ZDF rats and describes little evidence of an intrinsic impairment in animal models. This supports the cited sentence’s qualified statement that mitochondrial capacity appears intact. (LLM, conf=0.91)
- Supportedcites [3] 3. Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO. 2008. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105:7815–7820 [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Discussion reports that high-fat-fed rats developed muscle insulin resistance while their muscle mitochondria and capacity to oxidize fat increased. This supports the citing sentence’s qualified statement about mitochondrial capacity in an animal model. (LLM, conf=0.90)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although animal models of insulin resistance appear to have intact mitochondrial capacity (2, 3), humans with insulin resistance seem to have reduced mitochondrial capacity in skeletal muscle.”
- Also stated in: § Abstract · plain
“Decreased mitochondrial oxidative capacity has been reported as reduced electron transport chain activity (4, 5), mitochondrial fatty acid oxidation (6, 7), and oxidative phosphorylation in vivo (8, 9).”
What the sources say
- Not checked yetcites [4] 4. Simoneau JA, Kelley DE. 1997. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171 [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [5] 5. Kelley D, He J, Menshikova EV, Ritov VB. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes mellitus. Diabetes 51:2944–2950 [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [6] 6. Berggren JR, Boyle KE, Chapman WH, Houmard JA. 2008. Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am J Physiol Endocrinol Metab 294:E726–E732 [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [7] 7. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. 2000. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039–E1044 [DOI] [PubMed] [Google Scholar] source
- Supportedcites [8] 8. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671 [DOI] [PMC free article] [PubMed] [Google Scholar] source
The RESULTS subsection 'RATES OF MITOCHONDRIAL PHOSPHORYLATION AND RATIO OF INORGANIC PHOSPHATE TO PHOSPHOCREATINE' states that rates of mitochondrial phosphorylation in skeletal muscle were approximately 30 percent lower (P=0.01) in the insulin-resistant subjects than in controls, with a ~20 percent reduction in the inorganic phosphate–to–phosphocreatine ratio in soleus muscle; the main RESULTS paragraph likewise attributes the intramyocellular lipid increase to 'mitochondrial dysfunction'. The DISCUSSION generalizes this to insulin-resistant humans beyond the offspring group ('These results are similar to those in lean, elderly, insulin-resistant subjects, whose insulin resistance ... is most likely attributable to acquired defects in mitochondrial biogenesis, which lead to reductions in skeletal-muscle mitochondrial content'), so the hedged human-level claim ('seem to have reduced mitochondrial capacity in skeletal muscle') matches how our copy treats the topic, including its own hedging ('support the hypothesis', 'may be caused by'). (LLM, conf=0.85)
- Not checked yetcites [9] 9. Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR. 2007. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 56:720–727 [DOI] [PubMed] [Google Scholar] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In fact, we have shown that even in the insulin-resistant state, skeletal muscle mitochondria respond to training (17, 18, 21).”
What the sources say
- Partly supportedcites [17] 17. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE. 2007. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56:2142–2147 [DOI] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results report increased skeletal muscle mitochondrial density after a physical-activity and weight-loss intervention in people with type 2 diabetes. The Discussion says exercise training may have been the main driver, but the study could not separate its effect from weight loss. Thus, the paper supports mitochondrial responsiveness in this insulin-resistant population, but not an unqualified effect of training alone. (LLM, conf=0.83)
- Not checked yetcites [18] 18. Toledo FG, Watkins S, Kelley DE. 2006. Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J Clin Endocrinol Metab 91:3224–3227 [DOI] [PubMed] [Google Scholar] source
- Supportedcites [21] 21. Toledo FG, Menshikova EV, Azuma K, Radikova Z, Kelley CA, Ritov VB, Kelley DE. 2008. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 57:987–994 [DOI] [PubMed] [Google Scholar] source
The Discussion reports that the diet-plus-exercise group had a clear increase in skeletal-muscle mitochondrial content and oxidative capacity. It identifies the participants as obese and insulin-resistant and concludes that physical activity is a chief factor controlling mitochondrial capacity in insulin resistance. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Our data suggest that mitochondrial subpopulations are regulated differently in insulin-resistant subjects, an observation that draws a parallel with differential regulation of mitochondrial subpopulations in diabetic (Zucker diabetic fatty) rats (2).”
What the sources say
- Supportedcites [2] 2. Holloway GP, Gurd BJ, Snook LA, Lally J, Bonen A. 2010. Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats. Diabetes 59:819–828 [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Discussion (‘Mitochondrial morphology’; page not provided) reports increased subsarcolemmal mitochondrial number and density in ZDF rats, while intermyofibrillar number and density were unchanged. It explicitly concludes that mitochondrial subpopulations can respond differently in insulin-resistant muscle, supporting the cited parallel. The sentence’s finding in human subjects is presented as the citing authors’ own data, not as a finding attributed to this source. (LLM, conf=0.93)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There has been considerable published evidence for lower fasting lipid oxidation and lower ΔRQ in obesity and T2DM, at both the whole-body level and the tissue level (36–38).”
What the sources say
- Partly supportedcites [36] 36. Kelley DE, Mandarino LJ. 2000. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683 [DOI] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The “Metabolic inflexibility of fatty acid utilization in insulin resistance” section (page unavailable) reports reduced fasting muscle lipid oxidation in obesity; Fig. 3 describes little change in leg RQ between fasting and insulin stimulation in obesity and type 2 diabetes. The paper does not establish the same pattern at the whole-body level, and its discussion distinguishes leg measurements from systemic measurements. (LLM, conf=0.87)
- Not checked yetcites [37] 37. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130–E1141 [DOI] [PubMed] [Google Scholar]
- Partly supportedcites [38] 38. Kelley DE, Simoneau JA. 1994. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356 [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The muscle-metabolism results (p. 2352) show lower fasting lipid oxidation in leg tissue in NIDDM. The Discussion (p. 2352) reports that whole-body fasting lipid oxidation was similar in NIDDM and nondiabetic subjects, not lower. The paper does not establish lower ΔRQ at both levels or a finding for obesity generally. (LLM, conf=0.89)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
62 more claims
Create a free account to see all 106 claims and to verify the 59 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 22
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle from obese humans with or without diabetes is characterized by reduced overall mitochondrial content with evidence of morphological changes similar to those in the animal models (Chomentowski et al., 2011; Kelley et al., 2002; Ritov et al., 2005).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Chomentowski et al., 2011
Experimental — accuracy not yet measured
Citations
Cites
GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Stereological Methods. Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,994
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Self-citationFuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Skeletal muscle metabolism is a major determinant of resting energy expenditure.
Zurlo, F., Larson, K., Bogardus, C., & Ravussin, E. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114857 · Cited by 959
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Mitochondrial dysfunction and insulin resistance: an update
Montgomery, M. K., & Turner, N. (2015) · Endocrine Connections · doi:10.1530/ec-14-0092 · Cited by 527
Mechanical properties of whole-body soft human tissues: a review
Singh, G., & Chanda, A. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac2b7a · Cited by 364
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Skeletal muscle aging and the mitochondrion
Johnson, M. L., Robinson, M. M., & Nair, K. S. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.12.003 · Cited by 233
“Second, there are two distinct populations of skeletal mitochondria located in the subsarcolemmal (~20% of total mitochondrial content) and intermyofibrillar regions (~80% of total mitochondrial content) that are not uniformly released, due to differences in isolation technique and detergents [73,74].”
BackgroundDiabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells
D'Souza, D. M., Al-Sajee, D., & Hawke, T. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00379 · Cited by 223
The Key Role of Mitochondrial Function in Health and Disease
San-Millán, I. (2023) · Antioxidants · doi:10.3390/antiox12040782 · Cited by 218
“It is widely known that individuals with T2DM and metabolic syndrome are characterized by decreased mitochondrial content in both intermyofibrillar and subsarcolemmal skeletal muscle regions [151,152], mitochondrial oxidative enzymes [153], mitochondrial DNA, transcriptional factors and genes [154–156], and overall mi…”
BackgroundPeterson, M. D., Gordon, P. M., & Hurvitz, E. A. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01052.x · Cited by 176
Mitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases
Theurey, P., & Rieusset, J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.002 · Cited by 176
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 176
Carson, J. A., & Manolagas, S. C. (2015) · Bone · doi:10.1016/j.bone.2015.04.015 · Cited by 168
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking
Mittendorfer, B. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834ad8b6 · Cited by 156
Skeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
“However, there are discrepancies, as there has also been shown to be no differences in fibertype distribution between skeletal muscle biopsies from lean, nondiabetic individuals and individuals with obesity and T2DM (53).”
BackgroundThe effect of exercise on IL‐6‐induced cachexia in the ApcMin/+ mouse
Puppa, M. J., White, J. P., Velázquez, K. T., Baltgalvis, K. A., Sato, S., Baynes, J. W., & Carson, J. A. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0047-1 · Cited by 115
The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes
Martin, S. D., & McGee, S. L. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.019 · Cited by 113
Taub, P. R., Ramirez‐Sanchez, I., Ciaraldi, T. P., Perkins, G., Murphy, A. N., Naviaux, R., Hogan, M., Maisel, A. S., Henry, R. R., Ceballos, G., et al. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00357.x · Cited by 122
Carson, J. A., Hardee, J. P., & VanderVeen, B. N. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.005 · Cited by 103
Orlando, G., Balducci, S., Bazzucchi, I., Pugliese, G., & Sacchetti, M. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2658 · Cited by 101
Muscle mitochondria and insulin resistance: a human perspective
Hoeks, J., & Schrauwen, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.007 · Cited by 94
Metabolic Flexibility and Its Impact on Health Outcomes
Palmer, B. F., & Clegg, D. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.012 · Cited by 93
Toledo, F. G. S., & Goodpaster, B. H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.018 · Cited by 94
Self-citationColetta, D. K., & Mandarino, L. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00363.2011 · Cited by 90
Most, J., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.231 · Cited by 89
Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy
Peterson, M. D., Gordon, P. M., Hurvitz, E. A., & Burant, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2012 · Cited by 85
Li, Y., Vaitheesvaran, B., Hartil, K., Robinson, A. J., Hoopmann, M. R., Eng, J. K., Kurland, I. J., & Bruce, J. E. (2011) · Journal of Proteome Research · doi:10.1021/pr200313x · Cited by 84
Subcellular Specialization of Mitochondrial Form and Function in Skeletal Muscle Cells
Willingham, T. B., Ajayi, P. T., & Glancy, B. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.757305 · Cited by 85
Brockman, D. A., Chen, X., & Gallaher, D. D. (2014) · Journal of Nutrition · doi:10.3945/jn.114.191577 · Cited by 83
Mitochondrial Respiratory Capacity and Content Are Normal in Young Insulin-Resistant Obese Humans
Fisher-Wellman, K. H., Weber, T. M., Cathey, B. L., Brophy, P. M., Gilliam, L. A. A., Kane, C. L., Maples, J. M., Gavin, T. P., Houmard, J. A., & Neufer, P. D. (2014) · Diabetes · doi:10.2337/db13-0940 · Cited by 82
“The few studies that attempted to correlate indices of oxidative phosphorylation and/or mitochondrial content with insulin sensitivity did not find a significant relationship (12–14), but one did (8).”
BackgroundChen, L.-L., Zhang, H.-H., Zheng, J., Hu, X., Kong, W., Hu, D., Wang, S.-X., & Zhang, P. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.002 · Cited by 81
“[23] Chomentowski P, Coen PM, Radikova Z, et al.”
BackgroundCastillo, Í. M. P., Argilés, J. M. A., Rueda, R., Ramírez, M., & Pedrosa, J. M. L. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09954-9 · Cited by 83
Dynamic changes of muscle insulin sensitivity after metabolic surgery
Gancheva, S., Ouni, M., Jelenik, T., Koliaki, C., Szendroedi, J., Toledo, F. G. S., Markgraf, D. F., Pesta, D. H., Mastrototaro, L., De Filippo, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12081-0 · Cited by 80
Self-citationJunker, A., Wang, J., Gouspillou, G., Ehinger, J. K., Elmér, E., Sjövall, F., Fisher‐Wellman, K. H., Neufer, P. D., Molina, A. J. A., Ferrucci, L., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101628r · Cited by 80
Urbina-Varela, R., Castillo, N., Videla, L. A., & del Campo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207704 · Cited by 79
Giebelstein, J., Poschmann, G., Højlund, K., Schechinger, W., Dietrich, J. W., Levin, K., Beck‐Nielsen, H., Podwojski, K., Stühler, K., Meyer, H. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2456-x · Cited by 77
Mitochondrial Plasticity in Obesity and Diabetes Mellitus
Jelenik, T., & Roden, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4910 · Cited by 73
The C57Bl/6 mouse serves as a suitable model of human skeletal muscle mitochondrial function
Jacobs, R. A., Díaz, V., Meinild, A., Gassmann, M., & Lundby, C. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.070037 · Cited by 75
DeLany, J. P., Dubé, J. J., Standley, R. A., Distefano, G., Goodpaster, B. H., Stefanovic-Racic, M., Coen, P. M., & Toledo, F. G. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2512 · Cited by 66
Self-citationMohammadkhah, M., Murphy, P., & Simms, C. K. (2016) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2016.05.021 · Cited by 64
Tsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 64
The lifecycle of skeletal muscle mitochondria in obesity
Pileggi, C. A., Parmar, G., & Harper, M. (2021) · Obesity Reviews · doi:10.1111/obr.13164 · Cited by 61
“These hormonal axes are often dysregulated with obesity and disrupt satiety.6 Moreover, adipocyte hydrolysis of triglycerides promotes lipid accretion in nonadipose tissues including the liver and skeletal muscle.4 Research on the role of skeletal muscle in obesity has largely focussed on the development of insulin re…”
BackgroundInfluentialVarone, E., Pozzer, D., Modica, S. M. D., Chernorudskiy, A. L., Nogara, L., Baraldo, M., Cinquanta, M., Fumagalli, S., Villar‐Quiles, R. N., Simoni, M. G. D., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101176 · Cited by 62
Samjoo, I. A., Safdar, A., Hamadeh, M. J., Glover, A. W., Mocellin, N. J., Santana, J., Little, J. P., Steinberg, G. R., Raha, S., & Tarnopolsky, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066322 · Cited by 48
Tarpey, M. D., Davy, K. P., McMillan, R. P., Bowser, S. M., Halliday, T. M., Boutagy, N. E., Davy, B. M., Frisard, M. I., & Hulver, M. W. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.006 · Cited by 48
Dague, É., Genet, G., Lachaize, V., Guilbeau‐Frugier, C., Fauconnier, J., Mias, C., Payré, B., Chopinet, L., Alsteens, D., Kasas, S., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.006 · Cited by 54
Heo, J., No, M., Cho, J., Choi, Y., Cho, E., Park, D., Kim, T., Kim, C., Seo, D. Y., Han, J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002394r · Cited by 54
Taub, P. R., Ramírez‐Sánchez, I., Ciaraldi, T. P., Gonzalez‐Basurto, S., Coral‐Vázquez, R. M., Perkins, G. A., Hogan, M. C., Maisel, A. S., Henry, R. R., Ceballos, G. M., et al. (2013) · Clinical Science · doi:10.1042/cs20130023 · Cited by 52
Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance?
Genders, A. J., Holloway, G. P., & Bishop, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186948 · Cited by 51
“Studies examining mitochondrial size via TEM have also found either no change [36] or a decrease in mitochondrial size in both obese and T2D participants [5].”
BackgroundInfluentialBroskey, N. T., Daraspe, J., Humbel, B. M., & Amati, F. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00063.2013 · Cited by 47
Matravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46
“differently to various metabolic perturbations in obesity and type 2 diabetes (9, 19, 45) as well as changes in diet composition (8, 36).”
BackgroundAssociation of muscle fiber type with measures of obesity: A systematic review
Damer, A., El Meniawy, S., McPherson, R., Wells, G., Harper, M., & Dent, R. (2022) · Obesity Reviews · doi:10.1111/obr.13444 · Cited by 43
Lauritzen, H. P. M. M. (2013) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e318275574c · Cited by 38
Passive skeletal muscle response to impact loading: Experimental testing and inverse modelling
Takaza, M., Moerman, K. M., & Simms, C. K. (2013) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2013.04.016 · Cited by 44
Takahashi, T., Yamamoto, M., Amikura, K., Kato, K., Serizawa, T., Serizawa, K., Akazawa, D., Aoki, T., Kawai, K., Ogasawara, E., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220673 · Cited by 44
Kakehi, S., Tamura, Y., Takeno, K., Sakurai, Y., Kawaguchi, M., Watanabe, T., Funayama, T., Sato, F., Ikeda, S., Kanazawa, A., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00220.2015 · Cited by 43
Faron, J., Bernaś, T., Sas‐Nowosielska, H., & Klag, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117187 · Cited by 42
Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?
Calton, E. K., Miller, V. S., & Soares, M. J. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.1 · Cited by 42
Exercise as a tool to mitigate metabolic disease
Esteves, J. V. D. C., & Stanford, K. I. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00144.2024 · Cited by 41
Thrush, A. B., Dent, R., McPherson, R., & Harper, M. (2013) · FEBS Journal · doi:10.1111/febs.12399 · Cited by 42
Jacobs, R. A., Díaz, V., Soldini, L., Haider, T., Thomassen, M., Nordsborg, N. B., Gassmann, M., & Lundby, C. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls335 · Cited by 40
Serrano, N., Hyatt, J. K., Houmard, J. A., Murgia, M., & Katsanos, C. S. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2023 · Cited by 38
Mitochondria in the pathogenesis of diabetes: a proteomic view
Chen, X., Wei, S., & Yang, F. (2012) · Protein & Cell · doi:10.1007/s13238-012-2043-4 · Cited by 36
Structural functionality of skeletal muscle mitochondria and its correlation with metabolic diseases
Swalsingh, G., Pani, P., & Bal, N. C. (2022) · Clinical Science · doi:10.1042/cs20220636 · Cited by 35
Khamoui, A. V., Desai, M., Ross, M. G., & Rossiter, H. B. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000594 · Cited by 35
Carstens, M. T., Goedecke, J. H., Dugas, L., Evans, J., Kroff, J., Levitt, N. S., & Lambert, E. V. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-8 · Cited by 34
Castro‐Sepúlveda, M., Jannas-Vela, S., Fernández‐Verdejo, R., Ávalos-Allele, D., Tapia‐Curimil, G., Villagrán, C., Quezada, N., & Zbinden‐Foncea, H. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00025.2020 · Cited by 35
Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control
Fix, D. K., Hardee, J. P., Gao, S., VanderVeen, B. N., Velázquez, K. T., & Carson, J. A. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01063.2017 · Cited by 35
Zamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
RabGAPs in skeletal muscle function and exercise
Espelage, L., Al‐Hasani, H., & Chadt, A. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0143 · Cited by 33
Kras, K. A., Langlais, P. R., Hoffman, N., Roust, L. R., Benjamin, T. R., Filippis, E. A. D., Dinu, V., & Katsanos, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.006 · Cited by 31
Optimizing the measurement of mitochondrial protein synthesis in human skeletal muscle
Burd, N. A., Tardif, N., Rooyackers, O., & van Loon, L. J. C. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0211 · Cited by 27
Nil Whey Protein Effect on Glycemic Control after Intense Mixed-Mode Training in Type 2 Diabetes
Gaffney, K., Lucero, A. A., Stoner, L. R., Faulkner, J., Whitfield, P., Krebs, J. D., & ROWLANDS, D. S. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001404 · Cited by 30
Cheng, Z., Schmelz, E. M., Liu, D., & Hulver, M. W. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300747 · Cited by 30
Parry, H. A., Willingham, T. B., Giordano, K. A., Kim, Y., Qazi, S., Knutson, J. R., Combs, C. A., & Glancy, B. C. (2024) · The Journal of Physiology · doi:10.1113/jp286246 · Cited by 29
Bakke, S. S., Feng, Y., Nikolić, N., Kase, E. T., Moro, C., Stensrud, C., Damlien, L., Ludahl, M. O., Sandbu, R., Solheim, B. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119556 · Cited by 30
Pattanakuhar, S., Pongchaidecha, A., Chattipakorn, N., & Chattipakorn, S. C. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.09.012 · Cited by 29
Ispoglou, T., Wilson, O. J., McCullough, D., Aldrich, L., Ferentinos, P. P., Lyall, G. K., Stavropoulos‐Kalinoglou, A., Duckworth, L. C., Brown, M. A., Sutton, L., et al. (2023) · Biology · doi:10.3390/biology12070892 · Cited by 29
O’Brien, L. C., Chen, Q., Savas, J. F., Lesnefsky, E. J., & Gorgey, A. S. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3687-9 · Cited by 28
Mo, F., Zheng, Z., Zhang, H., Li, G., Yang, Z., & Sun, D. (2020) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2020.109916 · Cited by 27
Toledo, F. G. S., Miller, R. G., Helbling, N. L., Zhang, Y., & DeLany, J. P. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14333 · Cited by 27
Self-citationPattanakuhar, S., Sutham, W., Sripetchwandee, J., Minta, W., Mantor, D., Palee, S., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Nutrition · doi:10.1016/j.nut.2018.11.031 · Cited by 26
Vella, C. A., Paul, D. R., & Bader, J. O. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02371.x · Cited by 25
Dubé, J. J., Collyer, M. L., Trant, S., Toledo, F. G. S., Goodpaster, B. H., Kershaw, E. E., & DeLany, J. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz272 · Cited by 25
Self-citationParry, H. A., & Glancy, B. C. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100487 · Cited by 25
Mitochondria in the Aging Muscles of Flies and Mice: New Perspectives for Old Characters
del Campo, A., Jaimovich, E., & Tevy, M. F. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9057593 · Cited by 25
Padrão, A. I., Carvalho, T., Vitorino, R. M. P., Alves, R. M. P., Caseiro, A., Duarte, J. A., Ferreira, R. M., & Amado, F. M. L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.04.009 · Cited by 24
Garthwaite, T., Sjöros, T., Laine, S., Koivumäki, M., Vähä‐Ypyä, H., Verho, T., Norha, J., Kallio, P., Saarenhovi, M., Löyttyniemi, E., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2023 · Cited by 23
Impact of prolonged overfeeding on skeletal muscle mitochondria in healthy individuals
Toledo, F. G. S., Johannsen, D. L., Covington, J. D., Bajpeyi, S., Goodpaster, B. H., Conley, K. E., & Ravussin, É. (2017) · Diabetologia · doi:10.1007/s00125-017-4496-8 · Cited by 25
Self-citationMonaco, C. M. F., Proudfoot, R., Miotto, P. M., Herbst, E. A. F., MacPherson, R. E. K., & Holloway, G. P. (2017) · Diabetologia · doi:10.1007/s00125-017-4456-3 · Cited by 22
Glaves, A., Díaz‐Castro, F., Farías, J., Ramírez-Romero, R., Galgani, J. E., & Fernández‐Verdejo, R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.744187 · Cited by 21
Stimulatory Effects of Balanced Deep Sea Water on Mitochondrial Biogenesis and Function
Ha, B. G., Park, J., Hyun-Jung, C., & Shon, Y. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129972 · Cited by 21
Gong, Y., Liu, Y.-Y., Li, J., Su, L., Yu, S., Zhu, X., Cao, X., & Xiao, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113784 · Cited by 20
Metabolic flexibility across the spectrum of glycemic regulation in youth
Bacha, F. F., Bartz, S. K., Puyau, M. R., Adolph, A. L., & Sharma, S. (2021) · JCI Insight · doi:10.1172/jci.insight.146000 · Cited by 20
Carnero, E. Á., Bock, C. P., Distéfano, G., Corbin, K. D., Stephens, N. A., Pratley, R. E., Smith, S. R., Goodpaster, B. H., & Sparks, L. M. (2021) · Diabetologia · doi:10.1007/s00125-021-05535-y · Cited by 18
Self-citationLim, E. L., Hollingsworth, K. G., Smith, F. E., Thelwall, P. E., & Taylor, R. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2011 · Cited by 18
Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome
Moreno‐Asso, A., Altıntaş, A., McIlvenna, L. C., Patten, R. K., Botella, J., McAinch, A. J., Rodgers, R. J., Barrès, R., & Stepto, N. K. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0212 · Cited by 16
Li, Q., Jiang, X., Zhou, Y., Gu, Y., Ding, Y., Luo, J., Pang, N., Sun, Y., Pei, L., Pan, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210015 · Cited by 15
Yang, Z., Zhang, Z., Zhao, J., He, Y., Yang, H., & Zhou, P. (2019) · RSC Advances · doi:10.1039/c8ra09482a · Cited by 15
Metadata
- Authors
- Chomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., & Toledo, F. G. S.
- Affiliations
- University of Pittsburgh (US)
- Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213
- Corresponding author
- Toledo, Frederico G. S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-02-01
- Volume
- 96
- Issue
- 2
- Pages
- 494-503
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3048328
- OpenAlex
- W2030701030
- Cited by
- 163
- References
- 41
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 18 · 2020: 6 · 2019: 11 · 2018: 8 · 2017: 8 · 2016: 12 · 2015: 10 · 2014: 12 · 2013: 20 · 2012: 12
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (P30AG024827)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK-462, R01DK049200, 5R01-DK49200-08)
- National Center for Research Resources (M01RR000056, 5 M01 RR00056)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- insulin resistance, skeletal muscle mitochondria, interfibrillar mitochondria, subsarcolemmal mitochondria, metabolic flexibility, metabolic inflexibility, lipid oxidation, glucose disposal, type 2 diabetes, obesity, respiratory quotient, cardiorespiratory fitness, muscle fiber type
- MeSH terms
- Adult, Body Composition, Calorimetry, Indirect, Female, Glucose Tolerance Test, Humans, Immunohistochemistry, Insulin Resistance, Male, Microscopy, Electron, Middle Aged, Mitochondria, Muscle, Myofibrils, Obesity, Oxidation-Reduction, Sarcolemma, Anaerobic Threshold, Glucose Clamp Technique, Body Mass Index, Artifacts, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.